These gene-slicers may help tackle HIV, Alzheimer's, and brain cancer.
A recent roundup in The Economist looks at a few new ideas for gene therapy.
Study volunteer Jonathan Wyatt, for example, can now read three more lines on an optometrist's chart.
A new feature in Wired highlights scientific advances that may make gene therapy much safer and more widespread. But it's important to check whether the regulation of clinical trials has advanced equally well.
It's not a cure, but researchers hope inserting a few genes into T cell receptors can keep HIV cells at bay.
Next-generation cancer therapies are notoriously expensive. But maybe not for long.
We're tampering with genes to cure a rare metabolic disorder--and that's likely just the beginning.
The most detailed microscopic crystallography image ever created
In a rare success for gene therapy, sight is regained in one eye
Researchers hope to extend gene therapy success in restoring sight to colorblind monkeys
New research suggests transsexualism is indeed a genetic trait. But how conclusive is the study?
Stem cells, Parkinson's pills, and viruses that improve your DNA: The next generation of performance enhancers won't show up on a urine test
Cloning the green goo's factories for producing light-sensitive proteins could lead to more effective treatments for certain types of blindness
A new blood test promises to spot cancer and Alzheimerâ€™s long before you get sick
Can genetic engineers turn chickens into pharmaceutical factories?
One preeminent scientist tackles the moral and ethical issues that come with the business of genetically enhancing our biology.
So odd, yet so true
From the world's oldest mouse
A pioneering gene treatment for Parkinson's disease ignites fury -- and hope.
The battle over genetically modified food is over: Supercrops won. Now crops designed to yield drugs and vaccines have come close to slipping into our food supply. No one knows if they're safe, and everyone involved seems to have something to hide.